US › Healthcare

Vyome Holdings, Inc. (HIND)

US · Healthcare · Biotechnology

$2.17+0.23%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

$31,591

Revenue YoY

-97.2%

Net profit

$-962,910

Profit YoY

-165.3%

EPS

$-0.14

EPS estimate

$-0.18

Net margin

-3,048.1%

EPS came in at -0.14 against a street estimate of -0.18 — a beat of 20.1%.

Key statistics

Market cap

$14.8M

Forward P/E

0.0

P/B

2.20

Book value

$0.96

EPS (TTM)

$-1.56

52-week high

$18.60

52-week low

$1.75

50-day MA

$2.19

200-day MA

$3.10

Analyst view

with an average price target of $11.50.

Shareholding

Insiders

52.88%

Institutions

1.52%

Largest institutional holders

Fund	Stake
Geode Capital Management, LLC	0.37%
UBS Group AG	0.32%
The Colony Group LLC	0.21%
Vanguard Fiduciary Trust Co	0.17%
Vanguard Capital Management, LLC	0.13%
Royal Bank of Canada	0.08%
Tower Research Capital LLC	0.02%
Citigroup Inc	0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Vyome Holdings, Inc. — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.